Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Link Cell Therapies Inc.

Headquarters: San Carlos, CA, United States of America
Year Founded: 2021
Status: Private

BioCentury | Jun 6, 2024
Discovery & Translation

Science Spotlight: Engineered CD47 protects CAR T cells from macrophages and more

BioCentury’s roundup of translational innovations
BioCentury | Mar 7, 2024
Discovery & Translation

Science spotlight: Roche’s anti-TIGIT mAb benefits from Fc-driven effects and more

BioCentury’s roundup of translational innovations
BioCentury | Mar 30, 2023
Discovery & Translation

Crystal Mackall: a cell therapy innovator’s view on decision-making

How the Stanford professor and serial entrepreneur thinks about the academia-industry interface, pediatric programs and triaging innovations
BioCentury | Mar 24, 2023
Discovery & Translation

Link’s AND-gated CAR T cells, plus a rapid COVID test with PCR-like sensitivity and more

BioCentury’s roundup of translational news
Items per page:
1 - 4 of 4